Delivery Order SPE2DB22D3011-SPE2DB24FQ0YD
Award Date 4/29/24
Potential Completion Date 4/30/24
Potential Value $28K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,661.02 firm fixed price delivery order is for Gilenya 0.5 mg capsules, a medication used to treat multiple sclerosis. The contract has an ultimate completion date of August 11, 2022 and was awarded on August 10, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
- This federal contract award, valued at $21,271.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gilenya 0.5 mg capsules, a medication used for the treatment of multiple sclerosis. The award is a Firm Fixed Price Delivery Order that does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,754.94 firm fixed-price delivery order is for the supply of Gilenya 0.5 mg capsules, a medication used to treat relapsing forms of multiple sclerosis. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,038.09 firm fixed-price delivery order is for Gilenya 0.5 mg capsules, a medication used for the treatment of multiple sclerosis. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 29, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $45,054.04, is for the supply of Gilenya 0.5 mg capsules, a medication used to treat multiple sclerosis. The contract has a firm fixed price and is set to expire on May 14, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order, valued at $69,163.45, is for the supply of the prescription medication Gilenya 0.5 mg capsules. The contract is a firm fixed-price delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) on May 7, 2025. The $43,935.58 firm fixed-price delivery order is for the provision of the medication Gilenya 0.5 mg capsules, with a performance period extending to May 8, 2025. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which allows the company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,750.55 firm fixed-price delivery order is for the supply of Gilenya 0.5 mg capsules, with a completion date of September 20, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,254.50, is for the delivery of Gilenya 0.5 mg capsules. The contract has an ultimate completion date of November 4, 2024, and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Gilenya 0.5 mg capsules. The contract has a ceiling value of $26,277.64 and was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 23, 2023. The contract is not designated with a set-aside. Amerisourcebergen Drug...